In this study, SE of MAPK and PI3K/AKT/mTOR proteins were frequent in HCC samples from patients who underwent OLT as HCC treatment, indicating activation of these signalizing pathways in such population. The gene discussed is AKT1; the disease is hepatocellular carcinoma.